NUDT1 and osteosarcoma: A recent study identified redox signaling as a key factor that determines the sensitivity of normal and cancer cells to inhibition of a non-oncogenic addiction enzyme mutT homologue (MTH1) both in vitro (in osteosarcoma cells) and in vivo (in zebrafish embryo) [136].